New nasal device aims to quiet chronic runny nose

NCT ID NCT05937308

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This study is tracking 150 adults with chronic rhinitis (long-term runny nose and congestion) who are receiving treatment with the NEUROMARK device. The device uses radiofrequency energy to disrupt nerves in the nose, aiming to reduce symptoms. Researchers are collecting real-world data on safety and how well it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
NEUROMARK System (a device that uses radiofrequency energy to disrupt nasal nerves)
What this could lead to
If successful, this could confirm that the NEUROMARK device is a safe and effective option for reducing chronic rhinitis symptoms like runny nose and congestion.
What could go wrong
This is a single-arm registry, not a randomized trial, so results may be less definitive. There is a risk of side effects from the procedure, such as pain or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alabama Nasal & Sinus Center

    Birmingham, Alabama, 35242, United States

  • Breathe Clear Institute

    Torrance, California, 90503, United States

  • ENT & Allergy Texas

    McKinney, Texas, 75071, United States

  • Florida ENT & Allergy

    Brandon, Florida, 33511, United States

  • Kentuckiana ENT

    Louisville, Kentucky, 40205, United States

  • Metropolitan ENT

    Alexandria, Virginia, 22310, United States

  • Ogden Clinic

    Ogden, Utah, 84403, United States

  • Sacramento ENT

    Roseville, California, 95661, United States

  • Sensa Health

    Los Angeles, California, 90006, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.